"The story of her leadership of the Medicines and Healthcare products Regulatory Agency is of two huge imperatives — first, to chart a new path for the agency after Brexit forced it to leave the embrace of the European Medicines Agency, then to set the international pace in approving life-saving Covid vaccines and therapeutics."

https://www.ft.com/content/3907db25-5cca-4191-8158-56fd4e335e3f